Here's an example: Quote: In the near term, we have

New Post Public Reply Private Reply Replies (0) Message Board
jamiejaytrader redspeed #22110
Quote:
Here's an example:

Quote: In the near term, we have the opportunity to explore the potential sale of the division for cash (and maintain a royalty), IPO the entity, license the technologies to a third party, or evaluate other strategic options that may present themselves now that we have created critical mass. We intend to update our shareholders on progress in this area as significant events occur. Our main goal in any of these initiatives will be to maximize shareholder value. In the event of a ‘spin-out,’ Amarantus plans to maintain an equity ownership, in order to put a significant, growing equity asset on our balance sheet. We would also enable current shareholders to participate directly in our soon-to-be revenue generating diagnostics business via a stock dividend, while also maintaining an equity position in our therapeutics and discovery business units.



He laid out four options, but only one referred to one with the dividend. What happens is people take the all the possibilities, combine the best outcomes of each and then set their expectation to that.

He never said if they sell the company, they would do a dividend.



You are correct Redspeed, this is the part that i remembered from my memory.
Good find!

Reading it again, i see your point and i no longer expect a dividend, but it would be nice if we still got one somehow


Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 0

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 0

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 0

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 0

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 0

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 0

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 0

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading

Top 5 Most Recently Viewed Articles

Provident Financial Holdings: Navigating Challenges with Resilience

Updated Category News Views 113

Financial Overview of Provident Financial Holdings Provident Financial Holdings, Inc. (NASDAQ: PROV) has released its fiscal results, reflecting a journey through various economic challenges. Net income reported for the quarter ending June 30, 2025, reached $1.63 million, illustrating a decrease from the previous period and shedding light on the company’s adaptability...

Continue Reading
Nanobiotix Unveils Comprehensive Findings from Phase 1 Study

Updated Category News Views 193

Nanobiotix Announces Significant Findings in Pancreatic Cancer Treatment Nanobiotix has recently revealed the full results of a groundbreaking Phase 1 study focusing on JNJ-1900 (NBTXR3) and its effectiveness in treating pancreatic cancer. This study, conducted with a group of 22 patients suffering from locally advanced or borderline resectable pancreatic cancer, aims to...

Continue Reading
EverQuote Reports Impressive Q2 Growth with Strong Cash Flow

Updated Category News Views 147

EverQuote Achieves Remarkable Revenue Growth in Q2 EverQuote, Inc. (Nasdaq: EVER), a prominent name in the online insurance marketplace, has announced its financial performance for the second quarter, showcasing an impressive revenue growth of 34% year-over-year, reaching $156.6 million. This significant increase reflects the effectiveness of our business strategy and the...

Continue Reading
Collaborative Efforts to Enhance Medicaid Enrollment Processes

Updated Category News Views 170

The New Era of Medicaid Provider Enrollment In an exciting development for the healthcare sector, Noridian Healthcare Solutions, LLC, in collaboration with HHS Technology Group, LLC (HTG), is set to significantly streamline the Medicaid provider enrollment process. This partnership aims to enhance the experience of both healthcare providers and patients, ensuring better...

Continue Reading
Seamless Air Alliance Launches Innovative Wi-Fi Tracking Venture

Updated Category News Views 195

Seamless Air Alliance Launches Innovative Wi-Fi Tracking Venture Seamless Air Alliance (SAA) has stepped into a transformative phase with the announcement of a groundbreaking initiative aimed at measuring inflight Wi-Fi performance. As a leading player in developing global standards for inflight connectivity, SAA is on a mission to elevate the travel experience by...

Continue Reading